Director of Quality Assurance and Regulatory Affairs
Christopher Oligny is the Director of Quality Assurance and Regulatory Affairs for TRIO. Mr. Oligny holds a B.Sc. in biology from St. Bonaventure University in New York, a MPH from the Uniformed Services University in Bethesda, Maryland and completed the Physician Assistant Program at The George Washington University in Washington, D.C. He has worked with GlaxoWelcome, InterMune, Genentech, and Ipsen in various managerial and director roles, most recently as a Senior Quality Assurance Manager for Ipsen.
Mr. Oligny brings a wealth of experience in international quality assurance and clinical research. He has a clinical background in a wide range of disciplines, including neurology, infectious diseases, hepatology, dermatology, ophthalmology, vaccines, primary care, pediatrics, and oncology. He has experience with GxP quality systems, particularly those focused on organizations meeting the objectives of Good Clinical Practice (GCP) and Good Pharmacovigilance Practices (GVP). Additionally, Mr. Oligny has led audits, inspections, CAPA management, and Process Harmonization and Improvement activities. He is a skilled negotiator, able to develop networks and work cooperatively on a global level to achieve common quality goals, ensuring that TRIO is successful in its mission to introduce new oncology treatments via best-in-class solutions and services for clinical trials.